HERON THERAPEUTICS, INC. /DE/ Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- HERON THERAPEUTICS, INC. /DE/ share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 9.00K shares, a 87.84% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 287.00K shares, a 40.82% decline from fiscal 2024.
- HERON THERAPEUTICS, INC. /DE/ share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 485.00K shares, a 1725.37% increase from fiscal 2023.
- HERON THERAPEUTICS, INC. /DE/ share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 26.57K shares.
- HERON THERAPEUTICS, INC. /DE/ share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 0.00 shares, a 100.00% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | 9.00K shares derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-11 | 188.00K shares derived: sum of 4 quarters · filed 2026-05-11 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 287.00K shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 9.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | 326.00K shares derived: sum of 4 quarters · filed 2025-11-04 |
| 2025-06-30 | 179.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | 391.00K shares derived: sum of 4 quarters · filed 2025-08-08 |
| 2025-03-31 | 99.00K shares 10-Q · filed 2025-05-06 | 544.00K shares derived: sum of 4 quarters · filed 2025-05-06 |
| 2024-12-31 | 39.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 485.00K shares 10-K · filed 2025-02-27 |
| 2024-09-30 | 74.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 103.57K shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 332.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | |
| 2024-03-31 | 40.00K shares 10-Q · filed 2024-05-07 | |
| 2023-12-31 | -342.43K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | 26.57K shares 10-K · filed 2024-03-12 |
| 2022-12-31 | 0.00 shares 10-K · filed 2025-02-27 | |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 369.98K shares 10-K · filed 2022-02-28 |
| 2021-09-30 | 12.14K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | |
| 2021-06-30 | 286.95K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | |
| 2021-03-31 | 70.89K shares 10-Q · filed 2021-05-10 | |
| 2020-09-30 | 35.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 349.22K shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | 54.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | 565.22K shares derived: sum of 4 quarters · filed 2020-08-05 |
| 2020-03-31 | 70.00K shares 10-Q · filed 2020-05-06 | 1.32M shares derived: sum of 4 quarters · filed 2020-05-06 |
| 2019-12-31 | 190.22K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | 1.98M shares 10-K · filed 2020-03-02 |
| 2019-09-30 | 251.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 1.99M shares derived: sum of 4 quarters · filed 2020-03-02 |
| 2019-06-30 | 810.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | 2.13M shares derived: sum of 4 quarters · filed 2020-03-02 |
| 2019-03-31 | 732.00K shares 10-Q · filed 2019-05-09 | 2.26M shares derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-12-31 | 197.51K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | 1.53M shares 10-K · filed 2020-03-02 |
| 2018-09-30 | 394.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | 1.73M shares derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | 937.57K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | 1.97M shares derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | 435.00 shares 10-Q · filed 2018-05-10 | 1.15M shares derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | 398.61K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | 1.35M shares 10-K · filed 2020-03-02 |
| 2017-09-30 | 637.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | 1.10M shares derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-06-30 | 118.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | 582.36K shares derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-03-31 | 197.00K shares 10-Q · filed 2017-05-10 | 752.36K shares derived: sum of 4 quarters · filed 2019-02-22 |
| 2016-12-31 | 145.36K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | 798.36K shares 10-K · filed 2019-02-22 |
| 2016-09-30 | 122.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | 812.34K shares derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | 288.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | 860.34K shares derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | 243.00K shares 10-Q · filed 2016-05-05 | 933.34K shares derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | 159.34K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | 1.04M shares 10-K · filed 2018-02-27 |
| 2015-09-30 | 170.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | 920.50K shares derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | 361.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | 965.38K shares derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | 352.00K shares 10-Q · filed 2015-05-08 | 833.24K shares derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | 37.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | 756.59K shares 10-K · filed 2017-02-23 |
| 2014-09-30 | 214.88K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -3.07M shares derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | 228.87K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | 869.25K shares derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | 275.35K shares 10-Q · filed 2015-05-08 | 875.38K shares derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | -3.79M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | 537.03K shares 10-K · filed 2016-02-19 |
| 2013-09-30 | 4.15M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | |
| 2013-06-30 | 235.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | |
| 2013-03-31 | -63.00K shares 10-Q · filed 2013-05-10 | |
| 2012-12-31 | 0.00 shares 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |